Benign paroxysmal positional vertigo Ear, Nose and Throat
Conditions
Interventions
PATIENT ASSESSMENTS
Following consent patients will undergo ward-based assessments comprising a clinical history and examination, subjective questionnaires and balance tests, prior to randomisation to
Sponsors
Imperial College London
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: Patient Inclusion criteria: 1. Over the age of 18 years 2. Closed head injury as defined by CT imaging 3. Inpatient on major trauma or outlying ward 4. Able to give informed consent or consultee consent 5. Sufficient grasp of English to consent and complete outcome measures Staff inclusion criteria: 1. Members of ward staff involved in the trial 2. Able to consent to an audio-recorded interview
Exclusion criteria
Exclusion criteria: Patients exclusion criteria: 1. History of previous or current substance abuse 2. Orthopaedic or vascular cervical spine instability 3. Pregnant 4.Glasgow Coma Score at assessment less than 14 5. Medically unstable 6. Current prescription of Phenytoin 7. Active psychiatric disease, including those with a current or past history of active psychotic disease but not those with a past history of psychiatric disease Staff exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Trial recruitment and retention rates measured at the end of the trial 2 .Acceptability and fidelity of the intervention examined at the end of the trial 3. Incidence of adverse events measured at the end of the trial | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Frequency of BPPV measured at baseline, 4 and 12 weeks 2. Dizziness handicap measured using Dizziness handicap inventory at baseline, 4 and 12 weeks 3. Balance confidence measured using the Activities specific balance confidence scale at baseline 4 and 12 weeks 4. Mood measured using the hospital anxiety and depression scale at baseline, 4 and 12 weeks 5. Static and dynamic balance measured using the mCTSIB and mDGI at baseline and 4 and 12 weeks 6. Quality of life measured using quality of life after brain injury questionnaire at 4 and 12 weeks 7. Brain injury recovery measured using the glasgow outcome scale extended at 4 and 12 weeks | — |
Countries
England, United Kingdom
Outcome results
None listed